Following several years of rapid enrollment growth in the Affordable Care Act (ACA) Marketplaces that corresponded with temporary enhanced premium tax credits, enrollment fell for the first time in seven years in 2026, when those tax credits expired. Every state except for New Mexico saw a drop in ACA Marketplace enrollment from 2025 to 2026….
Luminai raised $38 million in Series B funding to scale its AI platform that automates healthcare administrative workflows. The company is working with Cleveland Clinic to expand the use of its system across high-volume processes, starting with referral management. The post Luminai Raises $38M With Cleveland Clinic Using Its AI for Hospital Operations appeared first…
To truly expand CAR T access and prepare for the wave of new T cell-based therapies coming through the pipeline, we must find better ways to manage CRS and ICANS. The post For Many, CAR T is a Miracle Therapy – We Need to Get it to More Patients appeared first on MedCity News.
In November, Montana voters safeguarded the right to abortion in the state’s constitution. They also elected a new chief justice to the Montana Supreme Court who was endorsed by anti-abortion advocates. That seeming contradiction is slated to come to a head this year. People on polar sides of the abortion debate are preparing to fight…
Some digital hypertension solutions produce meaningful clinical and economic outcomes, while others fall short, according to a new report from Peterson Health Technology Institute. The post Digital Hypertension Solutions Are Everywhere, But Which Truly Improve Outcomes and Lower Costs? appeared first on MedCity News.
How can healthcare providers contend with a regulatory environment that has never been more fragmented? Here are three lessons on why privacy is your competitive advantage. The post Privacy Rules Are Tightening, Again. Here’s How Your Healthcare Marketing Can Embrace Compliance to Thrive appeared first on MedCity News.
Regeneron Pharmaceuticals will share in development of Tessera Therapeutics’ TSRA-196, a Phase 1-ready gene-editing therapy for alpha-1 antitrypsin deficiency (AATD). Other companies developing genetic medicines for this rare disease include Beam Therapeutics, Wave Life Sciences, Korro Bio, and AIRNA. The post Regeneron Puts Up $150M to Partner on Tessera Gene-Editing Med for Rare Liver &…
By MIKE MAGEE Stanford neuroscientist, David Eagleman, reminded us this week that “A coherent explanation of consciousness eludes modern science.” That was his opening line in the New York Times book review of Michael Pollan’s latest effort, “A World Appears.” In it, Pollan asks innocently, “How does the brain generate a unified sense of self?”…
Healthcare organizations are starting to implement AI agents — autonomous, task-specific systems designed to perform functions with little or no human intervention. While initial adoption is focused mainly on non-clinical areas like scheduling and prior authorizations, experts predict that AI agents could eventually play a role in clinical decision-making, provided they meet rigorous safety and…
New research was published this week analyzing how AI can be used to better manage medications for senior patients who use multiple medications simultaneously. It analyzed FeelBetter’s AI platform, which pinpoints patients at high risk of deterioration and preventable hospitalization due to suboptimal medication management. The post AI Can Help Better Manage Polypharmacy Patients, Study…